Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1: A Population-Based Study

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 34-39

  Gammon, Marilie D ^a,b   Terry, Mary Beth ^c   Arber, Nadir ^f   Chow, Wong Ho ^g   Risch, Harvey A ^h   Vaughan, Thomas L ⁱ   Schoenberg, Janet B ^j   Mayne, Susan T ^h   Stanford, Janet L ⁱ   Dubrow, Robert ^h   Rotterdam, Heidrun ^d   West, A Brian ^k   Fraumeni Jr , Joseph F ^g   Weinstein, I Bernard ^e   Hibshoosh, Hanina ^d  

^a The University of North Carolina at Chapel Hill   (United States)

^b Howard Hughes Medical Institute   (United States)

^c University of Columbia   (United States)

^d Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^e New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g NATIONAL CANCER INSTITUTE   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j Special Epidemiology Program   (United States)

^k NEW YORK UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIN D1; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; SULINDAC SULFIDE;

ADULT; AGED; ARTICLE; BODY SIZE; CARDIA; CONTROLLED STUDY; ESOPHAGUS; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONFIDENCE INTERVALS; CYCLIN D1; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; STOMACH NEOPLASMS; UNITED STATES;

EID: 9144236811     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0198     Document Type: Article

References (27)

1. Weinstein, I. B. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis (Lond.), 21: 857-864. 2000.
2. Arber, N., Gammon, M. D., Hibshoosh, H.. Britton, J. A., Zhang. Y.. Schoenberg, J. B., Rotterdam, H., Fabian, I., Holt, P. R.. and Weinstein, I. B. Overexpression of cyclin D1 occurs in both squamous carcinoma and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. Hum. Pathol., 30: 1087-1092, 1999.
3. Arber, N., Lightdale, C., Rotterdam, H., Han, S. H., Sgambato, A., Yap, E.. Ahsan, H., Finegold, J., Stevens, P. D., Green, P. H., Hibshoosh, H., Neugut, A. I., Holt. P. R., and Weinstein, I. B. Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol. Biomark. Prev., 5: 457-459. 1996.
4. Bani-Hani, K., Martin, I. G., Hardie, L., Mapstone, N., Briggs, J. A., Forman, D.. and Wild. C. P. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J. Natl. Cancer Inst. (Bethesda), 92: 1316-1321. 2000.
5. Jenkins, G. J., Doak, S. H.. Parry, J. M.. D'Souza, F. R., Griffiths, A. P., and Baxter. J. N. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br. J. Surg., 89: 824-837, 2002.
6. Farrow, D. C., Vaughan. T. L.. Hansten. P. D., Stanford, J. L.. Risch. H. A., Gammon, M. D.. Chow W-H, Dubrow, R., Ahsan, H., Mayne, S. T., Schoenberg, J. B., West, A. B., Rotterdam, H., Fraumeni, J. F., Jr., and Blot, W. J. Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biomark. Prev.. 7: 97-102. 1998.
7. Corley, D. A., Kerlikowske, K., Verma, R., and Buffler, P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 124: 47-56, 2003.
8. Opitz, O. G., Harada, H., Suliman, Y., Rhoades, B., Sharpless, N. E., Kent, R., Kopelovich, L., Nakagawa, H., and Rustgi, A. K. A mouse model ol human oral-esophageal cancer. J. Clin. Investig., 110: 761-769, 2002.
9. Gammon. M. D., Schoenberg, J. B., Ahsan, H., Risch, H. A., Vaughan, T. L., Chow, W-H.. Rotterdam, H., West, A. B., Dubrow. R.. Stanford, J. B., Mayne. S. T.. Farrow. D. C.. Niwa, S., Blot, W. J.. and Fraumeni. J. F., Jr. Tobacco. alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst. (Bethesda), 89: 1277-1284, 1997.
10. Waksberg, J. Sampling methods for random digit dialing. J. Am. Stat. Assoc., 73: 40-46, 1978.
11. Chow, W-H.. Blot. W. J., Vaughan, T. L., Risch, H. A.. Gammon. M. D.. Stanford, J. L., Dubrow, R., Schoenberg, J. B.. Mayne, S. T., Farrow, D. C.. Ahsan, H., West, A. B., Rotterdam, H., Niwa, S., and Fraumeni, J. F., Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst. (Bethesda), 90: 150-155, 1998.
12. Vaughan, T. L., Farrow, D. C., Hantsen. P. D., Chow. W-H., Gammon, M. D.. Risch,. H. A.,. Stanford, J. L., Schoenberg, J. B., Mayne, S. T., Rotterdam, H.. Dubrow, R., Ahsan, H., West. A. B.. Blot. W. J., and Fraumeni, J. F., Jr. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs and other medications that promote gastroesophageal reflux. Cancer Epidemiol. Biomark. Prev.. 7: 749-756. 1998.
13. Farrow. D. C.. Vaughan. T. L.. Sweeney, C.. Gammon. M. D., Chow. W-H.. Risch, H. A.. Stanford. J. L.. Hansten, P. D., Mayne, S. T., Schoenberg, J. B., Rotterdam, H., Ahsan, H., West, A. B., Dubrow, R., Fraumeni, J. F., Jr., and Blot, W. J. Gastroesophageal reflux disease. use of H2 antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control, 11: 231-238. 2000.
14. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817. 1994.
15. Terry, M. B., Gammon, M. D., Schoenberg, J. B., Brinton, L. A., and Hibshoosh, H, Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women. Cancer Epidemiol. Biomark. Prev., 11: 1100-1103, 2002.
16. Hosmer, D. W.. and Lemenshow. S. Applied logistic regression. New York: John Wiley & Sons, 1989.
17. Schlesselman, J. J. Case-Control Studies. New York: Oxford University Press. 1982.
18. Jenkins. T. D., Mueller. A., Odze. R., Shahsafaei, A., Zukerberg, L. R., Kent. R., Stoner, G. D.. and Rustgi, A. K. Cyclin D1 overexpression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium. Oncogene, 18: 59-66, 1999.
19. Hussain,. S. S., Szabo. 1. L.. and Tamawski. A. S. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am. J. Gastroenterol., 97: 542-553. 2002.
20. 6k and down regulation of c-myc, cyclin D1, cyclin A. and proliferating cell nuclear antigen. J. Biol. Chem.. 275: 38261-38267. 2000.
21. Qiao. L.. Shiff. S. J., and Rigas, B. Sulindae sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells, Int. J. Cancer, 76: 99-104, 1998.
22. Dihlmann, S., Siermann, A., and von Knebel Doeberitz, M. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenute ¡3 0-catenin/TCF-4 signaling. Oncogene, 20: 645-653, 2001.
23. Goldberg, Y., Nassif, I. I., Pittas. A., Tsai. L. L., Dynlacht, B. D., Rigas, B., and Shiff, S. J. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene, 12: 893-901, 1996.
24. Han. E. K. H.. Arber. N., Yamamoto, H.. Lim, J. T. E., Delohery, T., Pamukcu, R., Piazza, G. A., Xing, W. Q., and Weinstein, I. B. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res. Treat., 48: 195-203, 1998.
25. 1 cell cycle arrest in human pancreatic cancer cell lines. J. Gastrointest. Surg., 4: 24-33, 2000.
26. Vaughan. T. L., Dristal, A. R.. Blount, P. L., Levine, D. S., Galipeau, P. C., Prevo, L. J., Sanchez, D. A., Rabinovitch. P. S., and Reid, B. J. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol. Biomark. Prev., 11: 745-752. 2002.
27. Terry, M. B.. Gammon. M. D.. Ng-Mak, D.. and Thompson, W. D. Re: "p53 protein overexpression in relation to risk factors for breast cancer". Am. J. Epidemiol., 147: 511-512, 1998.